If you need more lookups,
subscriptions start at $34 USD/month.
Peter Strumph Location
San Francisco, CA, US
Peter Strumph Work
Chief Executive Officer @ (June 2021 - Present)
Member of the BOD @ (January 2016 - Present)
Chief Executive Officer @ (January 2016 - June 2021)
SVP Clinical and Technical Operations @ (April 2013 - December 2015)
Chief Executive Officer (interim) @ (June 2010 - July 2012)
Chief Executive Officer @ (January 2007 - January 2009)
SVP Operations @ CV Therapeutics (January 1997 - January 2007)
Manager Operations Planning @ (January 1993 - January 1997)
Business Analyst @ (January 1991 - January 1993)
Project Engineer @ (January 1990 - January 1991)
Lieutenant @ (January 1986 - January 1990)
Peter Strumph Education
University of Pennsylvania - The Wharton School 1993-1995
University of Pennsylvania 1982-1986
Peter Strumph Skills
Biotechnology
Manufacturing
Commercial Operations
Strategic Planning
Clinical Development
Product Development
Commercialization
Finacial Management
SEC Financial Reporting
Business Development
Start-ups
Pharmaceutical Industry
Lifesciences
Technology Transfer
Medical Devices
Cross-functional Team Leadership
Business Operations
Leadership
R&D
Clinical Trials
Team Building
Sop
Research and Development R&d
Java
Management
Sales
Life Sciences
Start Ups
Cross Functional Team Leadership
Microsoft Office
Drug Development
Business Analysis
SQL
Biopharmaceuticals
Research and Development
Peter Strumph Summary
Peter Strumph, based in San Francisco, CA, US, is currently a Chief Executive Officer at Parvus Therapeutics Inc. Peter Strumph brings experience from previous roles at Amygdala Neurosciences Inc, Portola Pharmaceuticals and Codexis. Peter Strumph holds a 1993 - 1995 University of Pennsylvania - The Wharton School. With a robust skill set that includes Biotechnology, Manufacturing, Commercial Operations, Strategic Planning, Clinical Development and more. Peter Strumph has 4 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Peter Strumph?
Find contact details for 700 million professionals.